Stocktoria

Kraig Biocraft Laboratories, Inc. KBLB

Kraig Biocraft Laboratories, Inc. statistics & valuation

Market cap$123.1M

Market cap as of 2026-06-30. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
2016201720182019202020212022202320242025
Operating margin (%)
-9246.00% -2215.40% -239.00% 2016201720182019202020212022202320242025
Return on equity (%)
2016201720182019202020212022202320242025
Shares outstanding
773.6M 816.8M 816.9M 877.6M 974.3M 1.03B 1.04B 1.06B 2016201720182019202020212022202320242025
Net debt ($)
2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
-801.20% -2037.70% -1637.60% -387.50% -389.20% -266.20% -84.10% -93.70% -225.80% -141.20% 2016201720182019202020212022202320242025
Free cash flow margin (%)
-3183.90% -781.70% -61.40% 2016201720182019202020212022202320242025
Debt / equity (×)
2016201720182019202020212022202320242025
EPS ($)
$0.00 $0.00 $0.00 $0.00 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating margin———————-239.0%-2215.4%-9246.0%
Net margin———————-291.1%-2397.4%-9648.6%
FCF margin———————-61.4%-781.7%-3183.9%
Return on assets-141.2%-225.8%-93.7%-84.1%-266.2%-389.2%-387.5%-1637.6%-2037.7%-801.2%
Return on equity45.3%41.7%53.1%109.1%151.9%75.6%54.0%26.2%69.1%130.2%
Current ratio0.180.080.290.490.290.110.030.000.010.12

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.